Abstract
Heparin is commonly used as the sole procedural anticoagulant in patients undergoing primary PCI (PPCI). Use of Bivalirudin compared with platelet glycoprotein IIbIIIa inhibitors (GPI) has been associated with improved survival in this cohort. There are no data on the comparative effectiveness of
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have